Watch the GLP-1 &
GLP-2 Video
Rofé Medical staff shares their experience.
Medical Weight Management
GLP-1 and GLP-2 medications can be an effective component of a physician-supervised medical weight-management program for appropriate patients.
At Rofé Medical, treatment begins with a medical evaluation to determine whether prescription medication is appropriate for you. Your clinician considers your medical history, current medications, health conditions, treatment goals, and other relevant factors before prescribing.
FDA-Approved and Compounded Options
When clinically appropriate, your provider may prescribe an FDA-approved GLP-1 or GLP-2 medication. In certain circumstances, a patient may have a medical need that cannot be met by an FDA-approved medication. When legally permitted and medically appropriate, your provider may prescribe a patient-specific compounded medication to be prepared by a state-licensed 503A compounding pharmacy.
Compounded medications are not FDA-approved. They are prepared pursuant to an individual patient’s prescription and are not intended to be represented as generic versions of, or equivalent to, FDA-approved products.
The specific medication, formulation, dose, and treatment plan are determined by your licensed clinician based on your individual medical needs.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Physician-Supervised Treatment
Our medical weight-management program includes clinical evaluation and ongoing monitoring. Prescription medications are provided only when clinically appropriate and only after a valid patient-provider relationship and prescription have been established.
Treatment recommendations vary from patient to patient. There is no guarantee of a particular medication, dosage, rate of weight loss, or treatment outcome.
About the Author
Dr. Sasson Moulavi, MD
Board-certified in family medicine with 30+ years of experience in adult medicine.
April 21, 2026
